Archive for the ‘Breast Cancer’ Category
Thursday, February 28th, 2008
Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer.
The trial is open to women who have already developed an advanced form of breast or ovarian cancer and have ...
Posted in Breast Cancer | No Comments »
Tuesday, February 26th, 2008
A new US study found that women taking combined hormone therapy had an increased risk of otherwise avoidable abnormal mammograms and breast biopsies that compromised the ability of these two methods to help diagnose breast cancer.
The study was carried out by lead author Dr Rowan T Chlebowski, an investigator at ...
Posted in Breast Cancer | No Comments »
Monday, February 25th, 2008
Cytori Therapeutics (NASDAQ:CYTX) was informed that positive longer-term follow-up data were presented from an independent, investigator-sponsored breast reconstruction study in Japan. As part of the study, adipose tissue-derived stem and regenerative cells, processed with Cytori's Celution™ 600 System, were used to reconstruct breast tissue following partial mastectomy. New data from ...
Posted in Breast Cancer | No Comments »
Monday, February 25th, 2008
Genentech, Inc. (NYSE:DNA) announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for Avastin® (bevacizumab), in combination with paclitaxel chemotherapy, for the treatment of patients who have not received chemotherapy for their metastatic HER2-negative breast cancer. The approval is based on a Phase III study (E2100) that ...
Posted in Breast Cancer | No Comments »
Saturday, February 23rd, 2008
It would "not only be unscientific but unethical" for FDA to reject Genentech's colon and lung cancer treatment Avastin for use as metastatic breast cancer treatment, a Wall Street Journal editorial says (Wall Street Journal, 2/21).
FDA is scheduled to decide Saturday whether to approve Avastin for treatment of metastatic breast ...
Posted in Breast Cancer | No Comments »
Wednesday, February 20th, 2008
Gene expression technologies show "considerable potential for improving prognostic and therapeutic prediction" in early-stage breast cancer concludes a systematic review, published in the Annals of Internal Medicine, of the three currently available commercial assays. "But more needs to be learned about the extent of that improvement..... and how they are ...
Posted in Breast Cancer | No Comments »
Tuesday, February 19th, 2008
Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease*. These facts stress the importance of a quality-ensured early detection of breast cancer as well ...
Posted in Breast Cancer | No Comments »
Monday, February 18th, 2008
The incidence of breast cancer in parts of Asia is rising steeply and catching up with rates in the western world, Dr Louis Chow, Medical Director of the Comprehensive Centre for Breast Diseases, UNIMED Institute, Hong Kong told oncologists attending the recent 1st Asian Breast Cancer Conference in New Delhi, ...
Posted in Breast Cancer | No Comments »
Monday, February 18th, 2008
Patricia Terstenyak of the Northeast Ohio Affiliate received Susan G. Komen for the Cure's annual Outstanding New Volunteer Award at Komen's 2008 Affiliate Leadership Conference, Feb. 8-9, in Dallas.
As the world's largest breast cancer organization, Komen for the Cure's promise is to save lives and end breast cancer forever. Terstenyak, ...
Posted in Breast Cancer | No Comments »
